BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Authors » John Brosky

Articles by John Brosky

Breakthroughs in imaging are seen changing the way cardiology is practiced

Oct. 1, 2008
By John Brosky
MUNICH, Germany — The noise and confusion from the bells and whistles being added to cardiology imaging are driving growth and greater revenues for manufacturers, but far more importantly, the steady stream of upgrades and new features is bringing breakthroughs in medical practice. Scientific sessions featuring abstracts and research papers using high-tech modalities for imaging the human heart have grown to more than 20% of the total 363 scientific sessions over the four days of the European Society of Cardiology's (ESC; Sophia Antipolis, France) annual congress here early last month. (Biomedical Business & Technology)
Read More

International report: bioMérieux takes second step toward cancer 'theranostics'

Sep. 25, 2008
By John Brosky

Good news fails to slow Agfa stock price's continued slide

Sep. 25, 2008
By John Brosky

Report from Europe: bioMérieux takes second step toward cancer 'theranostics'

Sep. 23, 2008
By John Brosky

Report from Europe: Good news fails to slow continued slide by Agfa

Sep. 22, 2008
By John Brosky

Philips' strategy for cardiac imaging leads with research

Sep. 18, 2008
By John Brosky
MUNICH, Germany — Philips Healthcare (Eindhoven, the Netherlands/Andover, Massachusetts) stood out among the dozens of manufacturers of cardiac imaging equipment for European markets jockeying for mind-share with the 24,000 cardiologists participating in the annual congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) here earlier this month. (Diagnostics & Imaging Week)
Read More

New workstation creates novel views for cardiac imaging

Sep. 12, 2008
By John Brosky

Philips' strategy for cardiac imaging leads with research

Sep. 11, 2008
By John Brosky
MUNICH, Germany — Philips Healthcare (Eindhoven, the Netherlands/Andover, Massachusetts) stood out among the dozens of manufacturers of cardiac imaging equipment for European markets jockeying for mind-share with the 24,000 cardiologists participating in the annual congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) here last week. (Medical Device Daily)
Read More

Scan of heart's magnetic field is revolutionizing diagnosis

Sep. 11, 2008
By John Brosky

Imaging breakthroughs are 'disrupting' cardiac practice

Sep. 11, 2008
By John Brosky
MUNICH, Germany — The noise and confusion from the bells and whistles being added to cardiology imaging are driving growth and greater revenues for manufacturers, but far more importantly, the steady stream of upgrades and new features is bringing breakthroughs in medical practice. (Diagnostics & Imaging Week)
Read More
Previous 1 2 … 75 76 77 78 79 80 81 82 83 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 18, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing